The overexpression of transcription factors Phox2a/2b, Hand2 and Gata3 in LC improves NE and DA activity and function in PD rodent models, offering a therapeutic strategy for PD treatment [92]. The gene discussed is PHOX2A; the disease is Parkinson disease.